首页> 外文OA文献 >Recognition and ER Quality Control of Misfolded Formylglycine-Generating Enzyme by Protein Disulfide Isomerase
【2h】

Recognition and ER Quality Control of Misfolded Formylglycine-Generating Enzyme by Protein Disulfide Isomerase

机译:蛋白二硫代硫化物酶识别和ER质量控制被错误的甲炔生成酶的鉴别和ER质量控制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Summary: Multiple sulfatase deficiency (MSD) is a fatal, inherited lysosomal storage disorder characterized by reduced activities of all sulfatases in patients. Sulfatases require a unique post-translational modification of an active-site cysteine to formylglycine that is catalyzed by the formylglycine-generating enzyme (FGE). FGE mutations that affect intracellular protein stability determine residual enzyme activity and disease severity in MSD patients. Here, we show that protein disulfide isomerase (PDI) plays a pivotal role in the recognition and quality control of MSD-causing FGE variants. Overexpression of PDI reduces the residual activity of unstable FGE variants, whereas inhibition of PDI function rescues the residual activity of sulfatases in MSD fibroblasts. Mass spectrometric analysis of a PDI+FGE variant covalent complex allowed determination of the molecular signature for FGE recognition by PDI. Our findings highlight the role of PDI as a disease modifier in MSD, which may also be relevant for other ER-associated protein folding pathologies. : Impaired activity of misfolded formylglycine-generating enzyme (FGE) results in multiple sulfatase deficiency (MSD) in humans. Schlotawa et al. show that recognition and quality control of misfolded FGE by protein disulfide isomerase (PDI) play a crucial role in the manifestation of MSD as a severe disease. Keywords: endoplasmic reticulum, protein disulfide isomerase, protein folding, quality control, formylglycine, sulfatases, multiple sulfatase deficiency, lysosomal storage disorders, formylglycine generating enzyme, SUMF1
机译:总结:多硫酸酯酶缺乏症(MSD)是一种致命的,遗传溶酶体贮积病的特征在于减少的患者所有硫酸酯酶的活性。硫酸酯酶需要活性位点半胱氨酸至甲酰甘氨酸由所述甲酰甘氨酸生成酶(FGE)催化的独特的翻译后修饰。影响细胞内蛋白质的稳定性FGE突变确定MSD患者残余酶活性和疾病的严重程度。在这里,我们表明,蛋白质二硫键异构酶(PDI)在MSD-引起FGE变种识别和质量控制起着举足轻重的作用。 PDI的过表达减少了不稳定FGE的剩余活性变体,而PDI功能的抑制营救在MSD成纤维细胞硫酸酯酶的残余活性。通过PDI FGE识别分子签名的PDI + FGE变体共价复合物允许确定的质谱分析。我们的研究结果强调PDI的作用,在MSD疾病修改,这也可能是相关的其他ER-相关的蛋白质折叠疾病。 :错折叠的甲酰甘氨酸生成酶(FGE)的人类多种硫酸酯酶缺乏症(MSD)的结果受损活性。 Schlotawa等。显示由蛋白质二硫键异构酶(PDI)错误折叠FGE的是识别和质量控制扮演一个严重的疾病在MSD的表现至关重要的作用。关键词:内质网,蛋白质二硫键异构酶,蛋白折叠,质量控制,甲酰甘氨酸,硫酸酯酶,多硫酸酯酶缺乏症,溶酶体贮积症,甲酰甘氨酸生成酶,SUMF1

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号